Trends in Pharmacovigilance - Market Research and Future Impact, New Webinar Hosted by Xtalks
TORONTO, April 25, 2018 (Newswire.com) - In a live broadcast upcoming on Monday, May 14, 2018 at 1 p.m. EDT, industry experts Colleen LoConte, Senior Vice President of Customer Relationship Management at Bioclinica and Andrew Schafer, President of Industry Standard Research (ISR) will discuss an overview of key findings within recent pharmacovigilance market research conducted by ISR.
This presentation will offer insight into the latest trends, best practices and challenges small, mid and large size pharmaceutical companies face with pharmacovigilance internal processes and effectiveness, outsourcing and more. Learn what drivers and key challenges play critical roles in patient safety, complying with all health agency regulations and minimizing company risk. Also explored will be actual case studies and examples of how leading pharmaceutical companies today are partnering with Bioclinica to overcome internal pharmacovigilance challenges and develop best practices.
For more information about this complimentary session visit: Trends in Pharmacovigilance – Market Research and Future Impact.
About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical and biotech companies, private and academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com.
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Source: Xtalks
Share:
Tags: Bioclinica, drug safety and risk management, medical scientific liaison, patient safety, pharmacoviglance, Xtalks